Stemtech International and Marinova Pty Ltd agree to long-term strategic supply relationship
Marinova Pty Ltd, a privately-owned Australian biotechnology company, announced today that it has signed a long-term supply agreement with Stemtech International, a science-based company and one of the fastest growing direct marketing companies in the USA. Marinova has granted Stemtech the exclusive rights to use one of its proprietary marine plant extracts in their newly launched SE2 nutritional supplement.
Stemtech’s nutritional products support the release, circulation and migration of adult stem cells to tissues and organs. SE2 is a nutritional supplement that contains a patent-pending proprietary blend of extraordinary all-natural ingredients, including one of Marinova’s marine plant extracts. Stemtech’s wellness products are only available through its independent distributors and are not sold in retail stores.
A human clinical research study (Experimental Hematology: 35 (2007):989-994) conducted by Marinova at the Clinical Haematology and Medical Oncology Unit, Royal Hobart Hospital, Australia, demonstrated that ingestion of a particular marine plant extract (Undaria pinnatifida) caused CD34+ hemopoietic stem cells in the blood plasma to increase significantly. These are the cells that give rise to all lineages of immune cells in the body. In addition, the study found that the CXCR4 molecule population also increased substantially from taking the same ingredient. The CXCR4 molecule is an important adhesion molecule, which facilitates stem cell migration. Marinova’s Chief Scientist, Dr Helen Fitton, said “There are two particularly exciting findings from this trial: firstly, we found more adult stem cells in circulation; and secondly, we found that the stem cells had greater ability to migrate and adhere to where they were needed. This is a very promising development in an emerging and important area of stem cell research.”
On the supply relationship with Stemtech, Marinova’s CEO, Paul Garrott, said “We see a very bright future for Stemtech in this breakthrough area of natural stem cell research and wellness. They are, without doubt, the global leaders in ‘stem cell nutrition’. Our exclusive supply partnership will develop as Stemtech continues to grow. To this end, Marinova is committing to even further stem cell related research on the unique ingredient that we supply exclusively to Stemtech.”
For more information about Stemtech International, please visit www.stemtech.com.